Hexokinase
Hexokinases phosphorylates glucose to generate glucose-6-phosphate, the initial step in glucose metabolism. HK1 and HK2 are two subtypes of mitochondrial hexokinases whichs are also involved in antiapopotic and cell survival.
Products Related to Hexokinase(6)
- GC174302-Deoxy-D-glucoseCAS: 154-17-6Purity: >98.00%
2-Deoxy-D-glucose (2DG), is a glucose analogue, act as competitive glycolytic inhibitor.
- GC11532LonidamineCAS: 50264-69-2Purity: >99.00%
Lonidamine is an inhibitor of hexokinase, mitochondrial pyruvate carrier (with a Ki of 2.5μM in isolated rat liver mitochondria) and plasma membrane monocarboxylate transporter, and also inhibits mitochondrial complex II.
- GC155233-Bromopyruvic acidCAS: 1113-59-3Purity: >97.00%
3-Bromopyruvic acid is an antitumor agent able to inhibit aerobic glycolysis and oxidative phosphorylation, with IC 50 values of 15 and 35μM for pyruvate dehydrogenase (PDH) and isocitrate dehydrogenase (IDH), respectively.
- GC27499PROTAC HK2 Degrader-1CAS: 3033812-84-6Purity: >99.50%
PROTAC HK2 Degrader-1 is a proteolysis-targeting chimera (PROTAC) targeting hexokinase 2 (HK2), generated by conjugating the HK2 inhibitor Lonidamine with the CRBN E3 ubiquitin ligase ligand Thalidomide via a linker.
- GC70717Benitrobenrazide (Hexokinase 2 inhibitor 1)CAS: 2454676-05-0Purity: >98.00%
Benitrobenrazide (Hexokinase 2 inhibitor 1) inhibits glycolysis by directly targeting HK2.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC17430 | 2-Deoxy-D-glucose | 154-17-6 | >98.00% | |
2-Deoxy-D-glucose (2DG), is a glucose analogue, act as competitive glycolytic inhibitor. | ||||
| GC11532 | Lonidamine | 50264-69-2 | >99.00% | |
Lonidamine is an inhibitor of hexokinase, mitochondrial pyruvate carrier (with a Ki of 2.5μM in isolated rat liver mitochondria) and plasma membrane monocarboxylate transporter, and also inhibits mitochondrial complex II. | ||||
| GC15523 | 3-Bromopyruvic acid | 1113-59-3 | >97.00% | |
3-Bromopyruvic acid is an antitumor agent able to inhibit aerobic glycolysis and oxidative phosphorylation, with IC 50 values of 15 and 35μM for pyruvate dehydrogenase (PDH) and isocitrate dehydrogenase (IDH), respectively. | ||||
| GC27499 | PROTAC HK2 Degrader-1 | 3033812-84-6 | >99.50% | |
PROTAC HK2 Degrader-1 is a proteolysis-targeting chimera (PROTAC) targeting hexokinase 2 (HK2), generated by conjugating the HK2 inhibitor Lonidamine with the CRBN E3 ubiquitin ligase ligand Thalidomide via a linker. | ||||
| GC70717 | Benitrobenrazide (Hexokinase 2 inhibitor 1) | 2454676-05-0 | >98.00% | |
Benitrobenrazide (Hexokinase 2 inhibitor 1) inhibits glycolysis by directly targeting HK2. | ||||
| GC79709 | HK2-IN-4 | 2748366-80-3 | >99.50% | |
HK2-IN-4 is a selective hexokinase 2 ( HK2 ) inhibitor with an IC 50 value of 0.79 μM and a K d value of 0.41 μM. | ||||
